The UK BioIndustry Association (BIA) has urged the US Supreme Court to review a decision of a lower court that could hinder the development of new diagnostics and life-saving medicines.
The European Bioeconomy Alliance (EUBA) calls on the EU to lead a worldwide transition towards a renewable, low-carbon economy.
EuropaBio is highly concerned that the EU Commission continues the same practices of maladministration which were criticised by the European Ombudsman as recently as January 2016.
We welcome the decision by the EMA to routinely offer parallel scientific advice with HTA bodies and other relevant stakeholders as part of its scientific advice activities.
Comprehensive study reveals positive macro-economic data on the European Bioeconomy
EuropaBio welcomes the Ombudsman’s decision and the recognition that political difficulties cannot justify maladministration.
EuropaBio, COCERAL and FEFAC welcome the European Ombudsman’s decision on their complaint regarding the European Commission’s handling of authorisation applications for genetically modified (GM) food and feed for import and processing.
The European pharmaceutical industry welcomes the new report by IMS Health for the European Commission services on ‘The Impact of Biosimilar Competition’.
Leading EU agriculture and food industries repeated their call for innovation to be considered at every stage of the legislative process.